Ascentage soars during its first day on the Hong Kong exchange, following $53M debut
Ascentage Pharma’s IPO bounty might have been modest compared to previous public debuts on the Hong Kong stock exchange, but it’s proving popular among investors …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.